MICRUROL

Active

Private limited companyfounded 2009active for 17 yearsBosdreef(HRT) 7, 2200 Herentals, BelgiumKBO/BCE: BE 0818.627.342

Summary

MICRUROL has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.1m and a net result of €449,264. Equity is growing by about 34% per year across the filed financial years. Its solvency ranks better than 84% of 3,009 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

MICRUROLActiveChecked score 98/100

Risk analysis Report Compare

Activity

Specialist medical practice

NACE 86220

1 site

Size

€2.3mtotal assets 2025

Equity: €2.1m
Profit: €449,264

Turnover not published (abbreviated or micro format)

Financial health

98 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Structure

Clara CeyssensDirector
Kristof DurtDirector

2025 accounts 8 days early2 of 8 deeds summarised

Why 98raises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 18.33, cash €628,446Figures for financial year 2025 (filed 23-01-2026)Show the evidence

Checked score

Score 2025

98 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 81% of its sector peers (NACE 86, small)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 100=

equity 89.3% of total assets

Liquidity 84+27

short-term debt 5.0% · cash 26.9%

Profitability 93-3

return on assets 19.3%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,074 companies, NACE 86, small)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024highest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026lowest value 04-2026: < 0.1%● unchanged vs 03-2026lowest value 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €200,000 on 30-day terms is acceptable

Liquidity ample (current ratio 18.33, compared with 32.26 in 2024, above the usual 1.5; short-term debt: 5% and cash: 26.9% of total assets), and 10.7% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small): better than 77% on solvency, 78% on liquidity, 88% on profitability and 81% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises riskneutral

1 change of registered office in 24 months

Belgian Official Gazette

Sector: Human health activities (NACE 86)

KBO

Liquidity: current ratio 18.33, cash €628,446

NBB · annual accounts

Figures for financial year 2025 (filed 23-01-2026)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 23-01-2026, 8 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

8 days early

2024

2 days early

2023

2 days early

2022

20 days early

2021

5 days early

2020

34 days early

2019

39 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 16 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 26 January (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

30-06-2026 year end25-10-2026 today31-01-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

15-05-2026 Registered officeRegistered-office move
23-01-2026 Annual accounts filedfinancial year 2025 · abbreviated…
30-06-2025 Highest result from 2019 to 2025net €449,264 ▲3.6%

Key points

Positive: Among the best 14% on equitysector median €369,013 · 3,009 companies €2.1m View
Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
Positive: 7 profitable years in a rowprofit 2025: €449,264 7 years View

By topic

Financials

Financial year: 2025
Total assets: €2.3m
Profit: €449,264
Solvency: 89.3%

Total assets▲ 15.6%

Net result

20192025

Go to Financials

Board & ownership

Board: 2 members

Clara CeyssensDirector
Kristof DurtDirector

Go to Board & ownership

Timeline

Events: 23
Since: 2012
Next accounts: by 31-01-2027

30-06-2025Equity above €2m
29-01-2025Annual accounts filed
30-06-2024Liquidity more than 5 times

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: Specialist medical practiceNACE 86220
Founded: 17-09-2009
Year ends: 30-06
Peppol: Reachable for e-invoices

Go to Company details

Articles of association

Provisions read: 20

See the provisions in the deeds

Go to Articles of association

Key facts about MICRUROL

What is the company number of MICRUROL?: 0818.627.342. In Belgium the VAT number is the company number with BE in front: BE 0818.627.342.
Where is MICRUROL based?: The registered office is at Bosdreef(HRT) 7, 2200 Herentals.Company details
What does MICRUROL do?: According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of MICRUROL?: Private limited company (BV).
When was MICRUROL founded?: On 17-09-2009.
Is MICRUROL still active?: Yes, MICRUROL is an active enterprise in the KBO register.
What is the turnover of MICRUROL?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is MICRUROL profitable?: In financial year 2025, MICRUROL made a profit of €449,264.
Where can I find the annual accounts of MICRUROL?: MICRUROL filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MICRUROL due?: By 31-01-2027, for financial year 2026.Timeline